Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prednisolone and Vitamin B1, B6, and B12 in Patients With Post-COVID-19-Syndrome (PC19S) - a Randomized Controlled Trial in Primary Care

NCT05638633 is registered in ClinicalTrials.gov with Wuerzburg University Hospital as lead sponsor.

NCT NCT05638633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05638633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prednisolone and Vitamin B1, B6, and B12 in Patients With Post-COVID-19-Syndrome (PC19S) - a Randomized Controlled Trial in Primary Care
Lead sponsor
Wuerzburg University Hospital
Phase
Phase 3
Overall status
Completed
Start date
November 11, 2022
Completion date
January 30, 2025
Enrollment
321 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

post-covid-19 syndrome